Optimization of ACE-tRNAs function in translation for suppression of nonsense mutations
Nonsense suppressor transfer RNAs (tRNAs) or AntiCodon-Edited tRNAs (ACE-tRNAs) have long been envisioned as a therapeutic approach to overcome genetic diseases resulting from the introduction of premature termination codons (PTCs). The ACE-tRNA approach for the rescue of PTCs has been hampered by ineffective delivery through available modalities for gene therapy. Here we have screened a series of ACE-tRNA expression cassette sequence libraries containing >1800 members in an effort to optimize ACE-tRNA function and provide a roadmap for optimization in the future. By optimizing PTC suppression efficiency of ACE-tRNAs, we have decreased the amount of ACE-tRNA required by ∼16-fold for the most common cystic fibrosis-causing PTCs.
Authors
- Wooree Ko (ORCID: https://orcid.org/0000-0002-3432-640X)
- John D. Lueck (ORCID: https://orcid.org/0000-0002-1820-711X)
- Joseph J. Porter (ORCID: https://orcid.org/0000-0002-4542-0338)
- Emily G. Sorensen
Institutions
- University of Rochester (US)
Publication Details
- Journal
- Nucleic Acids Research
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1093/nar/gkae1112
- Citations
- 17
- Primary Topic
- RNA and protein synthesis mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 3.97
Funders
- Cystic Fibrosis Foundation
- Cystic Fibrosis Foundation Therapeutics
- University of Rochester
- National Institutes of Health